[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337338-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337338-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-pro-inflammatory-stem-cell-niche-drives-myelofibrosis-through-a-targetable-galectin-1-axis","A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis","","Myeloproliferative neoplasms are stem cell-driven cancers associated with a disease microenvironment that promotes harmful pathology. This work investigates how a pro-inflammatory stem cell niche contributes to the development of myelofibrosis and identifies a galectin-1–centered signaling mechanism. The study frames the galectin-1 axis as actionable and shows why targeting galectin-1 may provide therapeutic leverage against the niche-dependent disease program. ",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-pro-inflammatory-stem-cell-niche-drives-myelofibrosis-through-a-targetable-galectin-1-axis/337338/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-pro-inflammatory-stem-cell-niche-drives-myelofibrosis-through-a-targetable-galectin-1-axis/337338.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological niche mechanism does the study focus on in myelofibrosis?","Question",{"text":63,"@type":64},"The study focuses on a pro-inflammatory stem cell niche and how it drives myelofibrosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular axis is proposed as targetable?",{"text":68,"@type":64},"A targetable galectin-1 axis is presented as central to the disease-driving niche mechanism.",{"name":70,"@type":61,"acceptedAnswer":71},"Who are the correspondence contacts mentioned in the manuscript metadata?",{"text":72,"@type":64},"The manuscript lists correspondence to Professors Bethan Psaila and Adam J Mead, and Dr Guanlin Wang as lead contacts.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337338,1791255572,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Europe PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nEurope PMC Funders Group  \nAuthor Manuscript  \nSci Transl Med. Author manuscript; available in PMC 2024 November 04.  \nPublished in final edited form as:  \nSci Transl Med. 2024 October 09; 16(768): eadj7552 . doi:10.1126/scitranslmed.adj7552 .  \nA pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis  \nRong Li\\#1,2 , Michela Colombo\\#2,3 , Guanlin Wang\\#2,4,5,6,* , Antonio Rodriguez-Romera2 , Camelia Benlabiod2 , Natalie J. Jooss2 , Jennifer O’Sullivan2 , Charlotte K. Brierley2 , SallyAnn Clark2 , Juan M. Pérez Sáez8 , Pedro Aragón Fernández9 , Erwin M. Schoof9 , Bo Porse 10,11,12 , Yiran Meng2 , Abdullah O. Khan2,7 , Sean Wen2 , Pengwei Dong5 , Wenjiang Zhou5 , Nikolaos Sousos2 , Lauren Murphy2 , Matthew Clarke2 , Aude-Anais Olijnik2 , Zoë  \nC. Wong2 , Christina Simoglou Karali2 , Korsuk Sirinukunwattana 13 , Hosuk Ryou 14 , Ruggiero Norfo2 , Qian Cheng2 , Joana Carrelha 15 , Zemin Ren2 , Supat Thongjuea2 , Vijay A Rathinam 16 , Anandi Krishnan 17 , Daniel Royston 11,18 , Gabriel A. Rabinovich8,19 , Adam J Mead\\#2,18,* , Bethan Psaila\\#2,18,20,*  \n1CAMS Oxford Institute; University of Oxford; Oxford, United Kingdom (UK) .  \n2Medical Research Council Weatherall Institute of Molecular Medicine (MRC WIMM) and NIHR Biomedical Research Centre Hematology Theme; University of Oxford; Oxford, UK.  \n3 Human Technopole; Milan, Italy.  \n4MRC WIMM Centre for Computational Biology, University of Oxford; Oxford, United Kingdom.  \n5Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology; Fudan University, Shanghai, China.  \n6Qizhi Institute, Shanghai, China  \nThis work is licensed under a BY 4.0 International license.  \n*Correspondence to: Professors Bethan Psaila ([bethan.psaila@ndcls.ox.ac.uk](bethan.psaila@ndcls.ox.ac.uk), lead contact), Adam J Mead  \n([adam.mead@imm.ox.ac.uk](adam.mead@imm.ox.ac.uk)) and Dr Guanlin Wang ([guanlin_wang@fudan.edu.cn](guanlin_wang@fudan.edu.cn)).  \nAuthor contributions  \nConceptualization, supervision and project administration: B. Psaila, A.J Mead, G.A. Rabinovich. Funding acquisition: B. Psaila, A.J Mead, R.Li. Supervision of computational analysis: G. Wang, S. Thongjuea. Investigation: R.Li, M. Colombo, A. Rodriguez-Romera, N.Jooss, C.Benlabiod, C.K. Brierley, P. Aragón Fernández, S. Clark, Y. Meng, A. O. Khan, L.C. Murphy, A.-A. Olijnik, Z.C. Wong, C. Simoglou Karali, R. Norfo, J. Carrelha, Z. Ren. Validation: R.Li, M. Colombo. N.Jooss, C.Benlabiod. Methodology: R.Li, M. Colombo, G. Wang, S.Wen, K. Sirinukunwattana, H. Ryou, Q. Cheng, A. Krishnan, D. Royston, G. A. Rabinovich, B.Porse, E.Schoof. Original draft and editing: B. Psaila, A.J Mead, G.A. Rabinovich, R.Li, M. Colombo, G. Wang. Resources: A. O. Khan, J. O’Sullivan, J.M. Pérez Sáez, N. Sousos, C.K. Brierley, V.A. Rathinam, D. Royston, G.A. Rabinovich. Visualization: R.Li, M. Colombo, G. Wang, P. Dong, W. Zhou, K. Sirinukunwattana, H. Ryou. Data curation and analysis: G. Wang, J. O’Sullivan, S.Wen, P. Dong, W. Zhou, K. Sirinukunwattana, H. Ryou, Q. Cheng, C.K. Brierley, S. Thongjuea, A. Krishnan. All authors read and approved the submitted manuscript.  \nCompeting interests:  \nB. Psaila: Alethiomics (co-founder, equity holder, consultancy, research funding), Incyte (research funding, consultancy), Constellation Therapeutics (consultancy), Blueprint Medicines (advisory board, consultancy), Galecto (research funding), Novartis (paid speaking engagements, consultancy); GSK (consultancy, paid speaking engagements), BMS (consultancy) . AJM has received honoraria for consulting and speaker fees from Novartis, Celgene/BMS, Abbvie, CTI, MD-Education, Sierra Oncology, Medialis, Morphosys, Ionis, Mescape, Karyopharm, Sensyn, Incyte, Galecto, Pfizer, Relay Therapeutics, GSK, Alethiomics & Gilead. AJM has received research funding from Celgene/BMS, Novartis, Roche, Alethiomics and Galecto. AJM is co-fo","cbCaietsxSrdDkWh","https://ap.wps.com/l/cbCaietsxSrdDkWh","pdf",3023702,39,"English","# Abstract\n## Author contributions\n## Competing interests","[{\"question\":\"What biological niche mechanism does the study focus on in myelofibrosis?\",\"answer\":\"The study focuses on a pro-inflammatory stem cell niche and how it drives myelofibrosis.\"},{\"question\":\"What molecular axis is proposed as targetable?\",\"answer\":\"A targetable galectin-1 axis is presented as central to the disease-driving niche mechanism.\"},{\"question\":\"Who are the correspondence contacts mentioned in the manuscript metadata?\",\"answer\":\"The manuscript lists correspondence to Professors Bethan Psaila and Adam J Mead, and Dr Guanlin Wang as lead contacts.\"}]","A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis | PDF",1790018641,98,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/236a7010e3ce8cc9258f9b41f87d9376.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bf2dc74be11dfeb134a05dfee7f8d43.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c636fceb3e01a4046af77a2ff862955f.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74f5920432c475b601dfb5a6fd69eeda.webp",980,1268]